cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Catalyst Pharmaceuticals Inc
15 own
32 watching
Current Price
$15
$-0.06
(-0.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,524.99M
52-Week High
52-Week High
17.50000
52-Week Low
52-Week Low
11.55000
Average Volume
Average Volume
1.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
9.1246
iconMarket Capitalization1,524.99M
icon52-Week High17.50000
icon52-Week Low11.55000
iconAverage Volume1.05M
iconDividend Yield--
iconP/E Ratio9.1246
What does the Catalyst Pharmaceuticals Inc do?
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Read More
How much money does Catalyst Pharmaceuticals Inc make?
News & Events about Catalyst Pharmaceuticals Inc.
InvestorPlace
11 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Although people might not readily recognize these little-known stocks, they offer surprisingly robust upside potential. The post 7 Little-Known Stocks to Buy Now Before They Become the Next Big Thing appeared first on InvestorPlace...
Globe Newswire
12 months ago
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held today at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera will receive USD 90 million upfront at closing (USD75 million in cash and USD15 million equity investment), an additional USD10...
Globe Newswire
1 year ago
CORAL GABLES, Fla., May 01, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases today announced ...
Benzinga
1 year ago
read more...
Globe Newswire
1 year ago
CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases...
Frequently Asked Questions
Frequently Asked Questions
What is Catalyst Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Catalyst Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Catalyst Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Catalyst Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Catalyst Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Catalyst Pharmaceuticals Inc?
plus_minus_icon
What percentage is Catalyst Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Catalyst Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$15
$-0.06
(-0.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00